Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Anemia Drugs
... CAGR of 4.1% over the analysis period 2024-2030. Iron Deficiency Anemia, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the end of the ... Read More
-
Anticoagulants
... 9.2% over the analysis period 2024-2030. NOACs, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis period. Growth in ... Read More
-
Intravenous (IV) Iron Drugs
... 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$2.3 Billion by the ... Read More
-
Heparin-induced Thrombocytopenia - Market Insight, Epidemiology, and Market Forecast - 2034
... the initiation of heparin therapy. It is primarily caused by the formation of antibodies against platelet factor 4 (PF4) and heparin. The diagnosis of Heparin-induced thrombocytopenia is based on a combination of clinical assessment, laboratory ... Read More
-
Rare Hematology
... CAGR of 4.9% over the analysis period 2024-2030. Plasma Derived Factors, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$18.2 Billion by the end of the ... Read More
-
Hemophilia Drugs
... CAGR of 5.5% over the analysis period 2024-2030. Hemophilia A Drugs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$21.3 Billion by the end of the ... Read More
-
Hemoglobinopathies
... 7.1% over the analysis period 2024-2030. Sickle Cell Disease Indication, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$795.0 Million by the end of the analysis ... Read More
-
Desmopressin
... 5.6% over the analysis period 2024-2030. Injectable Solution, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$866.1 Million by the end of the analysis period. Growth ... Read More
-
Rare Hemophilia Factors
... at a CAGR of 5.6% over the analysis period 2024-2030. Fresh Frozen Plasma, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$246.9 Million by the end ... Read More
-
Iron Deficiency Anemia Therapy
... 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Oral Iron Therapy, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$11.1 Billion by ... Read More
-
Thalassemia Treatment
... CAGR of 6.5% over the analysis period 2024-2030. Blood Transfusion, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$560.0 Million by the end of the analysis ... Read More
-
Bleeding Disorders Treatment
... at a CAGR of 5.0% over the analysis period 2024-2030. Hemophilia A Treatment, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$12.3 Billion by the end ... Read More
-
Bloodstream Infection Testing
... at a CAGR of 6.9% over the analysis period 2024-2030. Conventional Testing, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$12.7 Billion by the end of ... Read More
-
Sickle Cell Disease Treatment
... 2030, growing at a CAGR of 18.7% over the analysis period 2024-2030. Blood Transfusion, one of the segments analyzed in the report, is expected to record a 19.3% CAGR and reach US$6.5 Billion by the ... Read More
-
Plasma Fractionation
... CAGR of 5.1% over the analysis period 2024-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.8 Billion by the end of the analysis period. ... Read More
-
Fanconi Anemia Drug Market, By Treatment Type (Hematopoietic Growth Factors, Gene Therapy, Stem Cell Transplantation, and Other Therapies), By Age Group (Pediatric Patients and Adult Patients), By Disease Stage (Early-stage Disease and Advanced-stage Disease), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... disorder that is marked by bone marrow failure, congenital defects, and an increased risk of developing cancer. Numerous organ systems are impacted by fanconi anemia. Fanconi anemia results from a defective gene that harms cells, ... Read More
-
Plasma Fractionation Market by Type of Company
... 9.2% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Type of Company In-house Manufacturers Contract Service Providers Scale of Operation Preclinical Clinical Commercial Type ... Read More
-
2025 Global Forecast for Hemophilia Treatment Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 to ... Read More
-
Blood Disease Drugs Industry Forecasts - China Focus
... in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market ... Read More
-
Blood Disease Drugs Companies in China
... rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s ... Read More
-
Blood Disease Drugs Markets in China
... growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, ... Read More
-
Acquired Hemophilia Treatment Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Prenatal and Newborn Genetic Testing Market Report by Product Type (Consumables, Instruments), Screening (Non-invasive Prenatal Testing, Chorionic Villus Sampling, Amniocentesis, Maternal Serum Screening), Disease (Downs Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia), End User (Hospital, Maternity and Specialty Clinics, Diagnostic Centers), and Region 2025-2033
... 11.04% during 2025-2033. The market share is experiencing steady growth driven by the growing demand for advanced diagnostic and screening devices, the thriving medical industry, and the rising prevalence of congenital malformations and genetic abnormalities ... Read More
-
Hematology Diagnostics Market Size, Share, and Analysis, By Product (Instrument, Consumables), By Test (Anemia, Hemoglobinopathy, Leukemia/Lymphoma Phenotyping, Hematology Pathophysiology, Complete Blood Count (CBC), and Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034
... Research Institutes) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034 PRODUCT OVERVIEW Hematology Diagnostics Market, valued at USD 4.5 billion in 2023, is anticipated to grow at ... Read More
-
Hematology Diagnostics Market Size, Share & Trends Analysis Report 2025-2033
... to 2033. The hematology diagnostics market refers to the sector that encompasses the technologies, equipment, and services used to diagnose and monitor blood-related diseases, including anemia, leukemia, clotting disorders, and other blood conditions. Hematology diagnostics ... Read More
Research Assistance
